Qingdao Baheal Pharmaceutical Holdings Limited’s Net Profit Rose 9.3% in First Three Quarters of 2022

Qingdao Baheal Pharmaceutical Holdings Limited (青岛百洋医药股份有限公司) (301015.SZ) reported a net profit of 335.4 million yuan in the first three quarters of 2022, up 9.3% year-on-year.

Meanwhile, the company posted 5.5 billion yuan in revenue, up 5.4% year-on-year.

At the end of the reporting period, it had 4.9 billion yuan in total assets and 2.7 billion yuan in total liabilities, with a liability-to-asset ratio of 56.2%.